Lv1
40 积分 2024-10-26 加入
Final analysis of the RESONATE-2 study: up to 10 years of follow-up of first-line ibrutinib treatment for CLL/SLL
5小时前
已完结
Transformation to diffuse large B‐cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population‐based study
1个月前
已完结
The Distinctive Nature of Thyroid MALT Lymphomas Including IRTA1 Expression
2个月前
已完结
Abstract 1097: Mechanisms of primary and acquired resistance to venetoclax in chronic lymphocytic leukemia (CLL)
3个月前
已关闭
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
6个月前
已关闭
KRAS: the Achilles’ heel of pancreas cancer biology
6个月前
已完结
皖公网安备34019202002308
